Sphingosine-1-Phosphate (S1P) promotes osteogenesis by stimulating osteoblast growth and neovascularization in a vascular endothelial growth factor (VEGF)-dependent manner.

Sphingosine-1-Phosphate (S1P) plays multiple roles in bone metabolism and regeneration. Here, we have identified a novel S1P-regulated osteoanabolic mechanism functionally connecting osteoblasts to the highly specialized bone vasculature. We demonstrate that S1P/S1PR3 signaling in osteoblasts stimulates vascular endothelial growth factor (VEGFa) expression and secretion to promote bone growth in an autocrine and boost osteogenic H-type differentiation of bone marrow endothelial cells in a paracrine manner. VEGFa-neutralizing antibodies and VEGF-Receptor inhibition by Axitinib abrogated osteoblast growth in vitro and bone formation in male C57BL/6 J in vivo following S1P stimulation and S1P lyase inhibition, respectively. Pharmacological S1PR3 inhibition and genetic S1PR3 deficiency suppressed VEGFa production, osteoblast growth in vitro and inhibited H-type angiogenesis and bone growth in male mice in vivo. Together with previous work on the osteoanabolic functions of S1PR2 and S1PR3, our data suggest that S1P-dependent bone regeneration employs several non-redundant positive feedback loops between osteoblasts and the bone vasculature. The identification of this yet unappreciated aspect of osteoanabolic S1P signaling may have implications for regular bone homeostasis as well as diseases where the bone microvasculature is affected such as age-related osteopenia and post-traumatic bone regeneration.